LI
DYN icon

LRI Investments’s Dyne Therapeutics DYN Stock Holding History

LRI Investments’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22 Buy
+1
New +$19 ﹤0.01% 1941

Other funds holding DYN

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $6.28B AUM 24.26% 1-Year Est. Return
DWM
Darwin Wealth Management Tampa, Florida $365M AUM 22.69% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

LRI Investments's DYN Position: Q2 2026 in Review

LRI Investments opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 1 share worth $22. The stake represents ﹤0.01% of the portfolio and ranks #1941 among its holdings.

40 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • LRI Investments held 1 share of Dyne Therapeutics worth $22 as of Q2 2026.
  • Dyne Therapeutics was a new LRI Investments position in Q2 2026.
  • Dyne Therapeutics made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1941 holding.
  • 40 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.